San Francisco, 19
November 2018: The global gene expression market is expected to reach USD 11.3 billion by 2025,
according to a new report by Grand View Research, Inc. Globally rising demand
for targeted molecular therapeutics coupled with rising adoption of precision
medicine is anticipated to fuel market growth.
Understanding gene
expression under different conditions as well as the effects it has on
different metabolic activities has opened various vistas for the development of
a novel generation of molecular therapeutics. Search for methods to manipulate
the way a coding DNA is expressed as a cure to different conditions arising due
to abnormally expressed genes is expected to drive market.
Target expression
analysis and single cell analysis using low- to mid- plex techniques to
identify smallest differences and correlations in gene expression. Novel
products focusing on with improved efficiency and reliability are launched for
smaller samples. Increased interest stem cell and gene therapy are projected to
propel revenue generation for the market.
Emerging NGS
technologies coupled with their drastically declining prices are anticipated to
boost adoption of gene expression techniques. Furthermore, government support
through initiatives such as Precision Medicine Initiative would encourage
private investments in the sector leading to market growth.
Drug discovery and
development was estimated with largest share owing to higher adoption in drug
response testing for severs and complicated diseases such as all types of
cancer, tuberculosis, cardiac conditions and rare genetic disorders. However,
clinical diagnostic application is projected with fastest growth owing to
rising demand for rapid and accurate diagnosis of complex diseases coupled with
their higher incidence.
Rising demand for
precision medicine, higher prevalence of genetic disorders, and rapid advances
in biotechnology is attributive to largest contribution to revenue by North
America. Owing to the presence of countries, witnessing rapid economic
developments and demand for better health care solutions Asia Pacific is
anticipated to witness the fastest growth.
Access Research Report
of Gene Expression
Analysis Market@: www.grandviewresearch.com/industry-analysis/gene-expression-analysis-market
Further key findings from the report suggest:
· RNA expression dominated the market with
respect to analysis technique as the increased interest of researchers has been
observed to have been directed to understanding RNA activity to better
understand its effects on diseases
· As there are a high number of products
available for low to mid-plexing of gene expression, the segment was observed
to have accounted for the higher share
· Rising focus on higher accuracy is
anticipated to drive growth of high-plex techniques.
· Moreover, increased focus on cancer genomic
is anticipated to bolster growth
· Introduction of improved data analytics
& interpretation with high turnaround efficiency coupled with increase in
incidences of target diseases are vital factor influencing R&D.
· Substantial adoption of gene expression
techniques the U.S. can be attributed for the largest share of North American
market.
· Asia Pacific is anticipated to witness a
high growth rate due to the presence of initiatives by key market participants
to enhance presence in these emerging economies due to the presence of untapped
potential
· Key players contributing in this market are
Qiagen, Quest Diagnostics Incorporated, Illumina, Bio-Rad Laboratories, Oxford
Gene Technology, TAKARA,Biocartis Group NV, MYRIAD GENETICS, INC.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/biotechnology
Grand View Research has
segmented the global gene expression analysis market on the basis of process,
product, capacity, technique, application, and region:
Process Outlook (Revenue, USD Million;
2014 - 2025)
·
Sample Collection
·
Purification
·
cDNA synthesis & conversion
·
PCR Analysis
·
Data analysis & interpretation
Product Outlook (Revenue, USD Million; 2014 - 2025)
·
Kits & Reagents
·
DNA Chips
·
Others
Capacity Outlook (Revenue, USD Million; 2014 - 2025)
·
Low- to Mid- Plex
·
High-Plex
Technique Category Outlook (Revenue, USD Million;
2014 - 2025)
·
RNA Expression
o
Northern Blotting
o
DNA Microarrays
o
PCR Techniques
o
RNA-Seq
·
Promoter Analysis
o
In vitro Transcription/Nuclear Run-On
Assays
o
Gel Shift Assays
o
Chromatin Immunoprecipitation (ChIP)
·
Protein Expression & Posttranslational
Modification Analysis
o
Western Blotting
o
2-D Gel Electrophoresis
o
Immunoassays
o
Mass Spectrometry
Application Outlook (Revenue, USD Million; 2014 -
2025)
·
Drug Discovery & Development
·
Clinical Diagnostics
·
Biotechnology & Microbiology
·
Others
Regional Outlook (Revenue, USD Million; 2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East and Africa (MEA)
Access Press Release of
Gene Expression Analysis Market@: www.grandviewresearch.com/press-release/global-gene-expression-analysis-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment